z-logo
open-access-imgOpen Access
Intravitreous Ranibizumab as Treatment for Macular Telangiectasia Type 2
Author(s) -
Rodrigo Pessoa Cavalcanti Lira
Publication year - 2010
Publication title -
archives of ophthalmology
Language(s) - English
Resource type - Journals
eISSN - 1538-3601
pISSN - 0003-9950
DOI - 10.1001/archophthalmol.2010.155
Subject(s) - macular telangiectasia , ranibizumab , medicine , ophthalmology , macular degeneration , telangiectasia , optometry , retinal , fluorescein angiography , dermatology , surgery , bevacizumab , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here